Skip to main content
. 2023 May 10;15(5):1449. doi: 10.3390/pharmaceutics15051449

Figure 7.

Figure 7

(a) Sketch of the (Poly-1/ICMV) multilayers decorated microneedle surfaces. (b) Microneedle application into the skin. (c) Hydrolytic degradation of Poly-1 releasing the ICMV. (d) ICMV delivery to skin APCs. Reprinted with permission from DeMuth et al. [92]. Copyright (2012) American Chemical Society.